Introduction
Mesial temporal sclerosis (MTS) is the most common pathological substrate of temporal lobe epilepsy (TLE) (1) . Temporal lobe epilepsy with MTS is one of the most common types of drug-resistant epilepsy referred for epilepsy surgery; it is often refractory to antiepileptic drugs (AEDs), but responds favorably to surgery (2, 3) . There is a relationship between febrile seizure (FS) in childhood and subsequent MTS, but this relationship is a controversial issue in the literature. In one study, MRI findings of a markedly hyperintense hippocampus in children with febrile status epilepticus was highly associated with subsequent mesial temporal sclerosis (4) .
However, there is also evidence that suggests a subtle, pre-existing hippocampal malformation may exist in some patients that may facilitate febrile convulsions and contribute to the development of subsequent MTS (5). The question whether TLE with childhood febrile seizures is a distinctive entity has been raised before in the literature (6, 7) . However, the findings in two previous studies are contradictory. One study identified TLE-FS as a phenotype that can be delineated from other TLE (6), while another study concluded that medial TLE with complex febrile seizure is not a distinct epilepsy syndrome (7).
The aim of this study was to evaluate the demographic and clinical manifestations of MTS-TLE with FS in childhood and identify potential differences as compared with manifestations observed in MTS-TLE without FS in a large surgical cohort. We also investigated the surgery outcome in these two groups of patients.
Material and Methods
In this retrospective study, all patients with a clinical diagnosis of drug resistant TLE due to mesial temporal sclerosis who underwent epilepsy surgery at Jefferson comprehensive epilepsy center were recruited. Patients were prospectively registered in a database from 1986 through 2014. The diagnosis of MTS-TLE was made by the epileptologists working at this institution based on clinical grounds (semiology), electroencephalographic (EEG) findings and imaging [magnetic resonance imaging (MRI)]. There was no age limit to enter the study. For all patients, a comprehensive presurgical evaluation including a 1.5-Tesla brain MRI (epilepsy protocol) was performed. Magnetic resonance imaging studies were analyzed by neuroradiologists, neurologists, and neurosurgeons with expertise in epilepsy. We classified patients as having MTS if they had clear signs of mesial temporal atrophy and/or sclerosis in their brain MRI. We did not have specific pathology results in many patients to study their pathological classifications. Patients with dual pathology and also patients with incomplete historical data were excluded from this study.
All patients were submitted to surgical treatment (i.e., anterior temporal lobectomy).
They all had to be under the care of an epileptologist at our institution for at least one year, postoperatively. They were followed for up to five years after their surgery (in many patients the data beyond five years of follow-up were missing). Seizure outcome was monitored periodically by office visits (by the treating physician), telephone contacts, and letters (by the nurse practitioners). Postsurgical outcome during follow-up was classified into two groups; sustained seizure freedom or relapse. Aura was not considered as a relapse; only postoperative tonic-clonic seizures and complex partial seizures were considered as relapse. 
Discussion
Mesial temporal sclerosis probably has different causes. A number of studies showed that febrile seizures are probably one causative factor for the later development of MTS and TLE.
However, the association between febrile seizures and TLE probably results from complex interactions between several genetic and environmental factors (7) . In this study we tried to investigate whether MTS-TLE with childhood FS is a distinct entity compared to MTS-TLE without FS. Interestingly, demographic and clinical characteristics of these two groups of patients were very similar. In contrast to the previous study by Heuser et al. (6), we did not observe any significant differences with regard to seizure semiology, family history and other characteristics between MTS-TLE patients with or without childhood FS. One probable explanation for these contradictory results is our different methodology, as we selected a very homogenous population of patients with TLE and MTS, while they studied a heterogeneous group of TLE patients including those with MTS. It seems that childhood febrile seizure that has been previously described as a distinguishing feature in the overall group of patients with TLE (6) loses its value when the subgroup of patients with MTS-TLE is examined.
With regard to the relationship between history of childhood febrile seizure and surgery outcome, the data in the literature is more conflicting. In our study, epilepsy surgery outcome was not different between patients with MTS-TLE and drug-resistant seizures, with or without history of childhood febrile seizure in the past. In a previous meta-analysis of predictors of epilepsy surgery outcome, febrile seizures was a strong prognostic indicator of seizure remission (odds ratio 0.48; 95% confidence interval 0.27-0.83) (8) . However, this study and most of the studies included in it, investigated a very heterogeneous population of patients with epilepsy (including those with MTS, among other etiologies), who underwent surgery for drug-resistant 8 seizures. Our finding that childhood FS is not a predictive factor of surgery outcome in patients with MTS-TLE is similar to those previous studies, which included patients with MTS only (9, 10). It seems that childhood febrile seizure that has been previously described as a predictor of favorable outcome in the overall group of patients receiving temporal lobe resections for drugresistant epilepsy is, in fact, a predictor of MTS and loses its predictive value when the subgroup of patients with MTS is examined (10).
Conclusion
When mesial temporal sclerosis is the pathological substrate of TLE, clinical manifestations and response to surgical treatment of patients are very similar in patients with history of febrile seizure in their childhood compared with those without such an experience. In other words, when the subgroup of patients with MTS-TLE and drug resistant seizures is examined history of childhood febrile seizure loses its value as a distinguishing factor in characteristics or predictive factor for surgery outcome.
Study limitations
This was a clinic-based series of patients with medically-refractory MTS-TLE and may not represent the full spectrum of MTS-TLEs. Besides, this study was retrospective and uncontrolled in design. Finally, possible lack of power to detect minor differences between the two groups should also be considered. However, we investigated a larger group of patients including 262 individuals compared with the Heuser's study (207 patients) (6) and we could not reproduce their results. The larger sample size increases the power of the study and decreases the chance of beta (type II) error. Type II errors arise frequently when the sample sizes are too small, 
